A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Tips to Avoid Getting Laid Off
Companies continue to announce fresh rounds of layoffs and hiring freezes so far this year. Teresa Lusk, life coach, joined Cheddar News to discuss what you can do to protect your job.
Vegan Ramen Brand Startup Immi Raises $10M in Serie A Financing
Immi is an Asian-American food brand that makes the world's first low-carb, high-protein and fully plant-based instant ramen. Kevin Lee, co-founder of immi, joined Cheddar News to discuss the company, which is backed by tennis superstar Naomi Osaka, R&B singer Usher and speed skater Apolo Ohno.
Load More